Evidence map›Paper›PMID 41697330›Full record

ReviewHNO2026

[Description and implementation of primary, secondary, and tertiary preventive strategies in otorhinolaryngology].

C Schmit, M Mayer, M Santer, D Dejaco, B Hofauer

Abstract readEnglish AbstractReview
In one paragraph

Review in HNO, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

C SchmitUniversitätsklinik für Hals‑, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck, Anichstraße 35, 6020, Innsbruck, Österreich.
M MayerKlinik und Poliklinik für Hals‑, Nasen- und Ohrenheilkunde, Uniklinik Köln, Köln, Deutschland.
M SanterUniversitätsklinik für Hals‑, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck, Anichstraße 35, 6020, Innsbruck, Österreich. Matthias.santer@i-med.ac.at.
D DejacoUniversitätsklinik für Hals‑, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck, Anichstraße 35, 6020, Innsbruck, Österreich.
B HofauerUniversitätsklinik für Hals‑, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck, Anichstraße 35, 6020, Innsbruck, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevention is gaining increasing importance in modern medicine. Its goal is to avoid, delay, or reduce the occurrence of diseases and thereby decrease the overall disease burden. In otorhinolaryngology, multiple opportunities exist for implementing preventive strategies. This article is intended to provide an introductory overview of the topic of prevention in otolaryngology, while detailed aspects will be addressed in subsequent articles of this special issue.

objectiveThis article provides an overview of established and emerging preventive measures in otorhinolaryngology and classifies them within the framework of primary, secondary, and tertiary prevention. A narrative review of relevant preventive approaches was conducted based on selected examples from current literature and clinical practice.

resultsPrimary prevention includes vaccination programs; public awareness campaigns on risk factors such as tobacco, alcohol, and oncogenic viruses; and occupational hearing protection. Secondary prevention comprises screening programs, particularly newborn hearing screening and audiometric testing in risk groups. Tertiary prevention involves oncologic follow-up care, hearing rehabilitation, and multimodal therapy for chronic tinnitus.

conclusionConsistent implementation of preventive strategies at all levels can substantially reduce disease burden and improve patients' quality of life. Given the increasing medical and economic challenges, prevention plays a key role in 21st-century otorhinolaryngology.

Indexed as

OtolaryngologyOtorhinolaryngologic DiseasesPrimary PreventionSecondary PreventionTertiary PreventionHumansRisk FactorsDisease burdenNoncommunicable diseasesPatient education as topicRisk factorsVaccination

Identifiers

PMID41697330
PMCPMC13009054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.